Literature DB >> 2332729

MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation.

E F Rosloniec1, L J Vitez, S Buus, J H Freed.   

Abstract

Seven synthetic peptides corresponding to the polymorphic regions of the alpha and beta chains of the I-Ak molecule were examined for their ability to inhibit the presentation of foreign antigens to antigen-specific, I-A-restricted T cell hybridomas. Two of the peptides, representing the sequences found in the first and third polymorphic regions (PMR) of the A alpha k chain (alpha k-1 and alpha k-3) were capable of inhibiting the presentation of three different HEL-derived peptide antigens to their appropriate T cells. In addition, the alpha k-1 peptide inhibited the presentation of the OVA(323-339) immunodominant peptide to the I-Ad-restricted T cell hybridomas specific for it. Prepulsing experiments demonstrated that the PMR peptides were interacting with the APC and not with the T cell hybridomas. These observations were confirmed and extended by the demonstration that the alpha k-1 and alpha k-3 peptides blocked the direct binding of HEL(46-61) to purified I-Ak and that the alpha k-1 peptide blocked the binding of OVA(323-339) to I-Ad. The binding competition experiments suggest that the alpha k-1 peptide binds to the I-Ak molecule from which it was derived with a Kd approximately 10(-5) M, while the alpha k-3 peptide binds slightly less well. These combined data, suggesting that class II-derived peptides can bind to MHC class II molecules, including the autologous molecule from which they are derived, have important implications for the molecular basis of alloreactivity and autoreactivity. Further, they suggest a possible mechanism by which selecting elements, involving only MHC molecules, may be generated in the thymus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332729      PMCID: PMC2187911          DOI: 10.1084/jem.171.5.1419

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity.

Authors:  J Yagüe; J White; C Coleclough; J Kappler; E Palmer; P Marrack
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Interaction between a "processed" ovalbumin peptide and Ia molecules.

Authors:  S Buus; S Colon; C Smith; J H Freed; C Miles; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen.

Authors:  G A Bishop; G Haughton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

5.  Antigen-presenting cells do not discriminate between self and nonself.

Authors:  G Winchester; G H Sunshine; N Nardi; N A Mitchison
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Antigen-specific. I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas.

Authors:  E Walker; N L Warner; R Chesnut; J Kappler; P Marrack
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

7.  Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen.

Authors:  R Shimonkevitz; S Colon; J W Kappler; P Marrack; H M Grey
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Synthesis of the antibacterial peptide cecropin A (1-33).

Authors:  R B Merrifield; L D Vizioli; H G Boman
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

9.  Cytolytic T cell hybridomas. III. The antigen specificity and the restriction specificity of cytolytic T cells do not phenotypically mix.

Authors:  W Haas; J Mathur-Rochat; P Kisielow; H von Boehmer
Journal:  Eur J Immunol       Date:  1985-09       Impact factor: 5.532

10.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  6 in total

1.  Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma.

Authors:  C E Malstrom; A L Kotsenas; B Jones
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer.

Authors:  H Kropshofer; H Max; H Kalbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

3.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

4.  Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar.

Authors:  Yoshihiko Sakurai; Bo Tang; Edward F Rosloniec; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

5.  Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression.

Authors:  S Itescu; S Rose; E Dwyer; R Winchester
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Comparison of peptides bound to spleen and thymus class II.

Authors:  P Marrack; L Ignatowicz; J W Kappler; J Boymel; J H Freed
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.